CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 60.29 CNY -1.54%
Market Cap: 6.9B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

CanSino Biologics Inc
Investor Relations

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Xuefeng Yu Ph.D.
Co-Founder, Executive Chairman, CEO & GM
No Bio Available
Dr. Tao Zhu Ph.D.
Co-Founder, Deputy GM & Chief Scientific Officer
No Bio Available
Dr. Dongxu Qiu MBA, Ph.D.
Co-Founder, Executive VP & Deputy GM
No Bio Available
Dr. Shou-Bai Chao Ph.D.
COO, Deputy GM & Executive Director
No Bio Available
Ms. Jing Wang
Chief Commercial Officer, Deputy GM & Executive Director
No Bio Available
Mr. Chunlin Xin
Senior Director of New Technology Department
No Bio Available
Mr. Yonghui Wu
Vice President of Marketing
No Bio Available
Mr. Jin Cui
Board Secretary
No Bio Available
Mr. Ming King Chiu FCIS, FCS
Joint Company Secretary
No Bio Available

Contacts

Address
TIANJIN
Tianjin
West District Biomedical Park, No. 185 South Avenue, West District, Economic and Technological Development Zone
Contacts
+862258213766.0
www.cansinotech.com